CSat Investment Advisory, L.P. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
CSat Investment Advisory, L.P. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2020$7,000
-22.2%
429
+14.7%
0.00%0.0%
Q2 2020$9,000
-40.0%
374
-55.7%
0.00%
-66.7%
Q1 2020$15,0000.0%845
+21.1%
0.00%
-25.0%
Q4 2019$15,000
-87.0%
698
-89.0%
0.00%
-88.9%
Q3 2019$115,000
+55.4%
6,349
+206.6%
0.04%
+38.5%
Q2 2019$74,000
+64.4%
2,071
+54.3%
0.03%
+13.0%
Q1 2019$45,000
+28.6%
1,342
+25.1%
0.02%
+9.5%
Q4 2018$35,000
+105.9%
1,073
+279.2%
0.02%
+110.0%
Q3 2018$17,000
-5.6%
283
-22.7%
0.01%0.0%
Q2 2018$18,0003660.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders